To Evaluate Clinical Efficacy ofAshtang Lavan Churnin Alcohol Addiction.

DOI: https://doi.org/10.47223/IRJAY.2022.5103

Abstract

Background- Alcoholism is a growing public health and socioeconomic problem around the world. Around 20% of the alcohol drank is absorbed by the stomach. The remaining 80% is mostly absorbed by the small intestine. The circulatory system also delivers alcohol to the liver, which uses a process known as
"metabolizing" to remove it from the bloodstream by converting it to a harmless molecule. Because the liver can only digest a certain amount at a time, the rest circulates throughout the body.

Aim- To assess the clinical efficacy of Ashtang Lavan in Alcohol addiction and withdrawal symptoms.

Materials and Methods- The clinical efficacy of Ashtang Lavan in the treatment of alcohol addiction and withdrawal symptoms was evaluated using a randomized single blind technique. Ashtang Lavan was administered to one group to help with hepatotoxicity and withdrawal symptoms such as sleeplessness, anxiety, and agitation. Before and after therapy, the Clinical Institute Withdrawal Assessment- Alcohol revised (CIWA-Ar) scale was used to examine the clinical symptoms of alcohol withdrawal. Clinical manifestations of alcohol withdrawals recorded between 5 and 10 hours after ceasing to drink were used as a baseline for before therapy, while clinical manifestations of withdrawals after 1 month were used as a baseline for after treatment.

Result- There were 26.66 percent of patients in one group who reported excellent alleviation.

Conclusion- Throughout the clinical trial, 36.00 percent of patients in one group were found to be de-addicted.